Open AccessMinimization of the risk of diabetic microangiopathy in rats by Nigella sativa
Author(s) -
Juraiporn Somboonwong,
Mariem Yusuksawad,
Somboon Keelawat,
Sirima Thongruay,
Ubon Poumsuk
Publication year - 2016
Publication title -
pharmacognosy magazine
Language(s) - English
Resource type - Journals
eISSN - 0976-4062
pISSN - 0973-1296
DOI - 10.4103/0973-1296.182169
Subject(s) - nigella sativa , diabetes mellitus , microangiopathy , medicine , endocrinology , glibenclamide , lipid profile , streptozotocin , triglyceride , oxidative stress , insulin , insulin resistance , cholesterol , traditional medicine
Microangiopathy is a chronic diabetic complication resulting from metabolic derangements, oxidative stress, and increased pro-inflammatory cytokine production. Nigella sativa Linn. is used as an herbal medicine that exerts hypoglycemic, antilipidemic, anti-inflammatory, and antioxidant effects.